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Abstract: Several intracellular metabolic pathways in which multiple genes have a role affect the aging process. One important genetic
factor associated with aging is klotho gene. In some recently published studies, klotho gene has also been associated with several types
of cancer and identified as a tumor suppressor gene. Therefore, elucidation of the control of klotho gene expression has become more
important. Results suggesting that the promoter region of human klotho gene could be epigenetically controlled by DNA methylation
have been reported. In contrast, a study revealing whether a change in the expression level of DNMT enzymes in the cells affects klotho
gene expression has not been found. Herein, the effects of DNMT3A and DNMT3B enzymes on the expression of klotho gene, an
important genetic factor relating to the aging process and some human cancer types, were investigated. For this purpose, the expression
levels of DNMT3A and DNMT3B in HEK293 cells were artificially changed, and the effect on klotho gene promoter activity was
investigated using a reporter gene. The results of this research showed that DNMT enzymes have negative regulatory effects on klotho
gene promoter organized as a chromatin structure, and they have an enhancing effect on promoter activity when it is located on plasmid
DNA. These results elucidate the control mechanism of human klotho gene expression.
Key words: Aging, DNA methylation, DNMT-3A, DNMT-3B, klotho

1. Introduction
The aging process is determined by both environmental
and genetic factors. Genes in particular play the biggest
role in the aging and lifespan of organisms. Klotho gene
is an important genetic factor related to aging. This gene,
identified during mutagenesis studies in mice, plays a
critical role in lifespan and the development of age-related
diseases in mammals (Kuro-o et al., 1997). Loss of klotho
can result in multiple aging-like phenotypes resembling
human aging such as arteriosclerosis, osteoporosis, skin
atrophy, pulmonary emphysema, and infertility (Kuro-o et
al., 1997; Nabeshima, 2002), while the overexpression of
Klotho extends lifespan by 20%–30% (Kurosu et al., 2005).
In humans, the klotho gene localized on chromosome
13 is composed of 5 exons and encodes a type-I single
pass transmembrane protein (Matsumura et al., 1998).
The klotho protein is defined as a multifunctional protein
involved in several metabolic pathways includingcalcium
and phosphate homeostasis (Imura et al., 2007; Alexander
et al., 2009; Razzaque, 2009), the insulin/IGF-1 signaling
cascade (Bartke, 2006), apoptosis (Ikushima et al., 2006),
angiotensin-II–induced events in the kidney (Negri, 2005),
and oxidative stress (Yamamoto et al., 2005). Recently,
klotho gene has been associated with the development
of several types of cancer (Lu et al., 2008; Usuda et al.,
* Correspondence: kadirturan@marmara.edu.tr

2011a, 2011b; Wang et al., 2011). In this regard, klotho
has been defined as a tumor suppressor gene (Xie et al.,
2013; Tang et al., 2015). On the other hand, the clinical and
histological severity of chronic kidney disease is related to
the degree of klotho promoter methylation (Chen et al.,
2013). It has, therefore, become more important to clarify
the control mechanism of klotho gene. Consequently,
investigations into the regulation of klotho gene expression
with epigenetic factors have accelerated in recent years (Jin
et al., 2015; Luo et al., 2015).
The promoter of the gene and upstream control
regions are the most important cis-acting factors
regulating gene expression. The upstream region of
human klotho gene promoter has rich CG islands. The CG
islands are candidates for methylation with DNA methyl
transferase (DNMT) enzymes. DNA methylation is one
of the most important epigenetic factors controlling gene
expression in eukaryotic organisms. In mammals, it has a
vital role in many events such as cell differentiation and
growth control, protection of chromosomal integrity,
parental imprinting, inactivation of X chromosome, and
regulation of gene expression (Chow and Brown, 2003;
Ting et al., 2004). There are some reports considering
the role of intracellular DNMT enzymes on klotho gene
regulation (Lee et al., 2010). However, there are several
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unknown points regarding control of klotho gene by DNA
methylation. In this study, the effect of DNMT enzymes on
klotho gene promoter activity was investigated to assemble
clues about the epigenetic control of klotho gene. For this
purpose, the enzyme expression of endogenous DNMT
enzymes was decreased with gene-specific siRNA or
increased with transient transfection of DNMT-expressing
plasmid vectors in human embryonic cells (HEK293). The
activity of human klotho gene promoter in these cells was
detected with previously constructed reporter plasmid
vectors encoding luciferase enzyme under the control of
human klotho gene regulatory elements (Turan and Ata,
2011). The results showed that DNMT enzymes upregulate
the activity of klotho promoter located on plasmid DNA,
but downregulate when it is organized as a chromatin
structure in stably transfected cells.
2. Materials and methods
2.1. Cell lines
Human embryonic kidney (HEK293) and mouse
fibroblastic Swiss3T3 were used for transient transfection
experiments. HEK293 cells were maintained at 37 °C under
5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM),
high glucose (Gibco, USA), supplemented with 10% (v/v)
fetal calf serum (Gibco, USA), penicillin (100 U/mL), and
streptomycin (100 µg/mL) (Gibco, USA). Swiss3T3 cells
were maintained under the same conditions as HEK293
cells with the exception of DMEM (low glucose) (Gibco,
USA).
2.2. Transient transfections
Plasmid DNAs were transiently transfected into HEK293
and Swiss3T3 cells by using 293fectin (Invitrogen,
#948289) and 25 kDa branched polyethylenimine (PEI;
Sigma-Aldrich, #408727), respectively. The cells were
seeded in 12-well or 24-well plates containing complete
DMEM and incubated for 20–24 h under standard culture
conditions. After incubation, cells were transfected with
1–2 µg of plasmid DNA. In the transfection experiment
with PEI, plasmid DNAs were diluted in OPTI-MEM
(Gibco, USA) at 20 ng/µL concentration and mixed with
an equal volume of PEI solution prepared in OPTIMEM at 60 ng/µL concentration. DNA transfection with
293fectin was carried out according to the manufacturer’s
instructions. Forty-eight hours posttransfection, the cells
were harvested for Western blot analysis or luciferase
enzyme assays or inspected under a fluorescent microscope
for gene expression and localization.
2.3. Construction of plasmid vectors
pCAGGS (Niwa et al., 1991) and pCHA plasmids kindly
provided by Dr Nagata (Nagata et al., 1998) were used
to construct expression vectors. pRL-CMV (Promega,
USA) control vector was used for normalization. All
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plasmids were amplified in Escherichia coli DH5α
grown in LB (+ Amp) liquid media and isolated with a
Plasmid Midi kit (Qiagen, Germany), according to the
manufacturer’s instructions. In order to construct pCHADNMTs encoding HA-tagged DNMTs, cDNAs of human
DNMT3A v.1, DNMT3B v.3, and DNMT3B v.7 were
cloned into pCHA plasmid. Human DNMT cDNAs were
isolated from HEK293 cells with reverse-transcription
PCR. Total RNA was extracted from HEK293 cell by using
an RNA extraction kit (Roche, #11828665001, Germany).
Then cDNA was prepared with reverse transcription by
using oligo-dT primers, according to the manufacturer’s
instructions. The gene coding regions were amplified
from this cDNA with PCR by using specific primers
5ʹ-AAGAATTCAAATGCCCGCCATGCCCTCCAG3ʹ and 5ʹ-AAGAATTCTTACACACACGCAAAATAC
TCCTTCAGCG-3ʹ for DNMT3A v.1 and 5ʹ-AAGAATT
CAAATGAAGGG AGACACCAGGC ATC-3ʹ and 5ʹ-AA
GAATTCCTATTC
ACATGCAAAGTAGTCCTTCAG
for DNMT3B v.3 and DNMT3B v.7. The PCR-amplified
DNMT fragments were digested with EcoRI restriction
enzyme (New England Biolabs, #R0101S), treated with
Klenow enzyme (New England Biolabs, #M0210L), and
purified from agarose gel. pCHA plasmid vector was
digested with MluI (New England Biolabs, #R0198S),
blunted with Klenow, and dephosphorylated with SAP
(Fermentas, #EF0511). The linearized vector was ligated
with purified DNMT fragments by using a ligation kit
(TaKaRa, #6022). The resulting expression vectors were
designated pCHA-DMT3A-v.1, pCHA-DNMT3B-v.3, and
pCHA-DNMT3B-v.7. The plasmids encoding the wildtype DNMT enzymes were constructed by subcloning
the full-length DMT3A and DMT3AB fragments into
the eukaryotic expression vector, pCAGGS. Full-length
DNMT fragments were generated from pCHA-DNMT
plasmid vectors by digestion with EcoRI. The resultant
DNA fragments were purified with agarose gel and ligated
with pCAGGS linearized by EcoRI digestion. The plasmids
encoding native DNMT enzymes were designated
pCAGGS-DMT3A-v.1, pCAGGS-DNMT3B-v.3, and
pCAGGS-DNMT3B-v.7. The nucleotide sequence
of each plasmid was confirmed by DNA sequencing.
Reporter plasmid vectors pHKP-Luc, pHKPDII-Luc, and
pHKPDVII-Luc, encoding luciferase under the control
of human klotho promoters, were generated as previously
reported (Turan and Ata, 2011).
2.4. Western blotting
The expression of DNMT genes cloned in pCHA and
pCAGGS plasmid vectors was detected with Western
blotting. HEK293 cells were seeded in 12-well plates (1 ×
105 cells/well), incubated under standard culture conditions
for 20–24 h, and transfected with 2 µg of related expression
vectors. After 48 h incubation, the cells were harvested in
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200 µL of SDS sample buffer. The proteins were separated
by electrophoresis through a 10% polyacrylamide gel in the
presence of 0.1% SDS and transferred to a nitrocellulose
membrane. First, the membranes were exposed to the
specific primary antibodies diluted at a 1:500 ratio in the
blocking solution (5% skim milk in Tris-buffered saline):
monoclonal mouse anti-HA (Millipore, #05-904) for
HA-tagged DNMTs, polyclonal rabbit anti-DNMT3A
(Santa Cruz, #H-295/20703) for native DNMT3A, and
monoclonal mouse anti-DNMT3B (Santa Cruz, #G9/376043) for DNMT3B-v.3 and DNMT3B-v.7. Then they
were exposed to the biotinylated secondary antibodies
(goat anti-mouse IgG; Millipore, #AP124B) or goat antirabbit IgG (Thermo Scientific, #31823) diluted at 1:3500
in Tris-buffered saline. The proteins were visualized with
streptavidin-conjugated alkaline phosphatase (Millipore,
#ES007) and its substrate BCIP/NBT (Millipore,
#NMM1581860).
2.5. Immunofluorescence assay
Swiss3T3 cells were grown on a glass coverslip in a 12-well
plate (2.5 × 104 cells/well) incubated at standard culture
conditions for 20–24 h. After 20–24 h incubation the cells
grown in each well were transfected with 1 µg of HAtagged DNMT or native-DNMT–expressing plasmids by
using PEI. At 48 h posttransfection, cells were fixed with
3% paraformaldehyde solution, permeabilized with 0.1%
NP-40, washed twice with PBS, and then treated with 1%
skim milk. The cells were incubated with monoclonal
mouse anti-HA, polyclonal rabbit anti-DNMT3A, or
monoclonal mouse anti-DNMT3B at 1:500 dilutions in
1% skim milk for 60 min and washed twice with 0.1% NP40 and once with PBS. Then cells were stained with FITCconjugated goat anti-mouse IgG (Chemican, #AB308F) or
anti-rabbit IgG (Millipore, #AP307F) at 1:500 dilutions in
1% skim milk. The coverslip was washed with 0.1% NP40 and mounted in 0.1% p-phenylenediamine and 80%
glycerol. Expressions and localizations of DNMTs in the
cells were visualized under a fluorescence microscope
(Olympus BX50).
2.6. Establishing of the stably transfected HEK293 cells
with reporter luciferase vectors
HEK293 cells were stably transfected with reporter
luciferase gene cloned under the control of human klotho
gene promoter. The cells were seeded in a 6-well plate (2 ×
105 cells/well) and grown for 20–24 h. Reporter plasmid
vectors were linearized with NdeI (NEB, #R0111S)
(pHKP-Luc and pHKPDII-Luc) or BglI (Fermentas,
#ER0071) (pHKP-DVII-Luc) restriction enzymes. Each
of the HEK293 cell cultures grown in 6-well plates were
co-transfected with 3 µg of one of the reporter vectors
and 0.3 µg of a hygromycin-resistant plasmid. Twentyfour hours posttransfection, the cells were transferred into
6-cm petri dishes and incubated in DMEM containing 75

µg/mL hygromycin B. The culture medium was replaced
with fresh medium containing hygromycin B at 3–4-day
intervals. The incubation continued until hygromycinresistant clones were formed. The resistant clones were
isolated with glass rings and grown in a 24-well plate. The
luciferase activity of stably transfected clones was detected
with commercial luciferase reagent.
2.7. Knock down of DNMT3A in HEK293 cells with
DNMT3A-siRNA
HEK-293 or stably transfected HEK293 cells were
transfected with siRNA specific for DNMT3A (Santa
Cruz, #sc-37757) for downregulation of endogenous
DNMT3A gene expression. The cells were grown in a
6-well plate (2.5 × 105 cells/well) and incubated for 20 h.
After the incubation period, the cells were transfected
with 100 pmol DNMT3A-siRNA (Santa Cruz, #sc-37757)
or negative control siRNA (Santa Cruz, #sc-37007) by
using Lipofectamine RNAiMAX (Invitrogen, #13778075) transfection reagent, according to the manufacturer’s
instructions. Forty-eight hours post transfection, the
cells were transferred to 6-cm petri dishes containing
fresh DMEM medium and incubated for an additional
48 h. Then a quarter of the cells were used for total RNA
isolation and semiquantitative RT-PCR. The remaining
cells were transfected with DNMT expression vectors
or directly used for quantification of reporter luciferase
activity in the stably transfected cells.
2.8. Analysis of DNMT3A transcript in siRNAtransfected cells
The DNMT3A transcripts were detected with
semiquantitative PCR. Total RNA was isolated
from HEK293 cells transfected with siRNA, as
mentioned above (2.3). Reverse transcription was
carried out with oligo-dT primer. DNMT3A cDNA
was amplified with PCR by using specific primers of
DNMT3A: 5ʹ-AGCTGCCTACGCACCACCTC-3ʹ and
5ʹ-GCCGCAGCAGCCCGTAGGTA-3ʹ. PCR products
were analyzed with 7.5% native polyacrylamide gel. PCR
samples were mixed with 6X DNA loading buffered at a
1:5 ratio and loaded to gel. Electrophoresis was carried
out in TBE buffer at 80 V for 60 min. DNA bands were
visualized by staining the gel in deionized distillated water
containing EtBr at 0.2 µg/mL concentration.
2.9. Firefly and Renilla luciferase assays
The luciferase activities were determined using
commercially available reagents. Briefly, transiently or
stably transfected HEK293 cells grown in 24-well plates
were harvested, washed twice with PBS, and lysed in a
Renilla lysis buffer (Promega, #E291A). Luminescence
was detected with a single tube luminometer (20/20n
single tube luminometer; Promega), according to the
manufacturer’s instructions. The Firefly luciferase activity
was normalized relative to the Renilla luciferase activity.
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2.10. Statistical analysis
The sample groups were compared using the nonparametric
Mann–Whitney test. Statistical analyses were performed
using SPSS for Windows, version 17.0 software. P < 0.05
defined statistical significance.
3. Results
3.1. Construction of expression vectors
Human DNMT3A gene is located on the short arm
of chromosome 2 at 23.22 position and consists of 22
introns and 23 exons. The DNMT3B gene, having the
same number of exons, is located on the long arm of
chromosome 20 at 11.22 position (Figure 1). This work
started with cloning of DNMT cDNAs into mammalian
expression vectors. Gene-specific cDNAs were amplified
by PCR by using HEK293 cell cDNA. A single variant of
DNMT3A (DNMT3A-v.1) and two variants of DNMT3B
(DNMT3B-v.3 and DNMT3B-v.7) were obtained. DNMT
cDNAs were cloned in both pCAGGS and pCHA plasmid
vectors for expression of native DNA methyl transferase
(DNMT) enzymes, and HA-tagged DNMT enzymes
for distinguishing endogenous enzymes, respectively.
The expression of DNMTs cloned on plasmid vectors
in HEK293 cells was analyzed by Western blotting. The
localization of these proteins in transiently transfected
cells was demonstrated with immunofluorescence assay.

The results showed that DNMT3A and DNMT3B enzymes
encoded by expression vectors were efficiently synthesized
in transiently transfected HEK293 cells (Figure 2A) and
localized in the nucleus of Swiss3T3 cells. The localization
of DNMT enzymes was not affected by the presence of HA
tag (Figure 2B).
3.2. The effect of overexpression of DNMTs on a reporter
gene under the control of human klotho promoter
The quantities of DNMT3A and DNMT3B enzymes in
HEK293 cells were increased by transient transfection. The
effects of overexpression of DNMT enzymes were analyzed
by quantitation of luciferase expression from a reporter
plasmid carrying the luciferase gene under the control of
human klotho gene promoter. In the experiments, three
different reporter vectors (pHK-luc, pHKPDVII-luc, and
pHKPDVIII-luc) with different sized upstream regions of
human klotho gene promoter (Turan and Ata, 2011) were
used. The relative luciferase activities, as a ratio of Firefly
luciferase to Renilla luciferase in lysates prepared from
cells co-transfected with DNMT expression vectors and
reporter vectors, are given in Figure 3.
Unexpectedly, the increase in DNMT gene expression
in the cells did not lead to a reduction in reporter
luciferase activity, as shown in Figure 3A. On the contrary,
a statistically significant increase (P < 0.05) of luciferase
activity was observed in the cells overexpressing DNMT

Figure 1. Genomic localization and structure of DNMT3A (locusID-NCBI, 1788) and
DNMT3B genes (locusID-NCBI, 1789).
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Figure 2. A. Western blot analysis of DNMT expression in HEK293 cells.
The native DNMT3A and DNMT3B enzymes were visualized with rabbit
polyclonal anti-DNMT3A and mouse monoclonal anti-DNMT3B antibodies,
respectively. The DNMT enzymes tagged with the HA epitope were visualized
with monoclonal anti-HA antibodies. The protein bands were visualized using
SA-AP and the chromogenic substrate with BCIP-NBT. B. Expression and
localization of DNMT enzymes in Swis3T3 cells. HA-tagged DNMT enzymes
were visualized with monoclonal anti-HA antibody and FITC-conjugated
monoclonal anti-mouse IgG antibodies. For visualization of native DNMT
enzymes, rabbit polyclonal anti-DNMT3A, mouse monoclonal anti-DNMT3B,
and FITC-conjugated secondary antibodies were used.

enzymes. The overexpression of DNMT3A resulted in a
much greater increase in reporter activity. Similar reporter
activity profiles were observed in experiments carried
out with plasmid vectors encoding HA-tagged DNMT
enzymes (data not shown). The dose-dependent effect of
DNMT3A on human klotho promoter is shown in Figure
3B. A correlation was observed between the increase in
DNMT3A enzyme and reporter luciferase activity.
3.3. The effect of DNMTs on human klotho promoter in
stable transfected HEK-293 cells
The DNA molecules of eukaryotic cells are packaged as
chromatins in the nucleus. In contrast, plasmid DNA
in transiently transfected cells will not be organized as
a chromatin structure. HEK293 cells stably transfected
with reporter vectors were established because DNA

molecules behaved differently, either relaxed or organized
as chromatin via protein factors. The stably transfected
cell clones were selected in the presence of hygromycin
antibiotic. The cell clones were controlled for transgene
by using genomic PCR, and the luciferase activities of
lysates prepared from these cells were measured (data not
shown). DNMT enzymes were overexpressed in stably
transfected HEK293 cells with transfection of expression
vectors encoding HA-tagged DNMT (hDNMT) enzymes.
The Firefly luciferase activities in lysates of cells of
overexpressing DNMT enzymes were normalized with
Renilla luciferase activity (Figure 4). The results showed
that the increase of hDNMT3A enzyme in the stably
transfected cells with pHKP-luc reporter vector had no
significant effect on human klotho promoter (P = 0.74).
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Figure 3. A. The effects of overexpressed DNMT enzymes on luciferase reporter gene expression in HEK293 cells. The cells were
grown in 24-well plates containing complete medium for 20–24 h and co-transfected with 100 ng of DNMT expression vector, 100 ng
of reporter luciferase vector, and 50 ng of control pRL plasmid vector (for each well), as shown in figures. B. Dose-dependent effect
of DNMT3A on reporter gene expression. HEK293 cells grown in 24-well plate were co-transfected with 100 ng of reporter luciferase
vector, 50 ng of control pRL plasmid, and different amounts of DNMT3A expression vectors mentioned in figures. Total amount of
plasmid DNA for each well was adjusted to 300 ng with pCAGGS vector. Error bars represent standard deviations.

In contrast, hDNMT3B variants lowered more than 50%
of reporter luciferase activity in the same cells (P < 0.05).
The increase in hDNMT3B variants in the two other cell
lines showed similar effects on reporter gene expression,
but lower than in pHKP-luc cells. However, the effects of
hDNMT3B variants were statistically significant compared
with the control (vector) (P < 0.05).
3.4. The effect of knock down of endogenous DNMT3A
on klotho gene promoter activity in stably transfected
HEK293
In order to reduce the amount of endogenous DNMT3
enzyme, HEK-293 cells and the cells stably transfected
with reporter plasmids, were transfected with the siRNA
of DNMT3A. The reporter luciferase gene expression
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levels in DNMT3 knocked-down cells were determined.
First, the amounts of endogenous DNMT3 transcripts
in cells transfected with siRNA were determined by
semiquantitative RT-PCR. The results given in Figure 5A
showed significant reduction of DNMT3A transcripts
in cells transfected with specific siRNA. Then reporter
luciferase activity in these cells was measured (Figure
5B). The background activity in the control HEK-293 cell
lysates was equalized to 1, and the luciferase activities of
other samples were compared to that. The results showed
a statistically significant increase in reporter luciferase
activity in DNMT3A-siRNA–transfected HEK-293 cells
having stable reporter genes (P < 0.03).
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Figure 4. The effects of DNMT enzymes on luciferase reporter gene expression in stably
transfected HEK293 cells. The cells were grown in a 24-well plate and co-transfected with
100 ng of DNMT expression vectors, 50 ng of control pRL plasmid, and 100 ng of pCHA.
After 48 h incubation, the cells were harvested and luciferase activities in lysates were
detected. Error bars represent standard deviations.

4. Discussion
DNA methyl transferase enzymes have great importance
for the epigenetic regulation of gene expression in humans
and other mammalian organisms. Several reports indicate
that methylation of the promoter region downregulates
klotho gene expression. It is suggested that this situation
has an important role in the occurrence of diseases
such as breast and gastric cancers (Wang et al., 2011;
Rubinek et al., 2012). Hypermethylation in the promoter
regions of genes leads to repression of the related gene’s
expression, whereas methylation in the transcribed region
has a variable effect on gene expression (Singal et al.,
2002). In human cells, three different enzymes, DNMT1,
DNMT3A, and DNMT3B, which are responsible for DNA
methylation, have been characterized (Okano et al., 1998;
Robertson, 2002). Among these enzymes, DNMT1 is
predominantly responsible for copying and maintaining
DNA methylation patterns after DNA replication (Spada et
al., 2007). However, DNMT3A and DNMT3B are involved
in the establishment of new DNA methylation (de novo
methylation) patterns (Okano, et al. 1998). In this work, the
effects of DNMT3A and DNMT3B, which are responsible
for de novo methylation in klotho gene promoter activity,
were evaluated.
The upstream of klotho gene, including the promoter
region, is very rich in terms of CpG repeats, which are the
target sequences for DNMTs. It is suggested that klotho gene
expression is strictly regulated by DNA methylation, as an
epigenetic factor (Wolf et al., 2008; Lee et al., 2010; Wang
et al., 2011). In contrast, there are limited data showing the
direct effect of DNA methylation on control of klotho gene

expression. Here, human klotho gene promoter activity in
the overexpression of DNMT enzymes or knock-down cells
for these genes was detected with reporter luciferase gene
under the control of klotho promoter. Reporter plasmid
vectors carrying the luciferase gene under the control of
human klotho promoter were co-transfected with DNMTs
expressing vectors. Reporter plasmids would not carry
a human-specific DNA methylation pattern because of
amplification in E. coli. Therefore, it is thought that plasmid
DNA will be a target for the DNMT enzymes responsible
for de novo methylation in mammalian cells. As shown in
Figure 3A, contrary to expectations, the increase of DNMT
enzymes in transfected cells upregulated human klotho
promoter activity. These results were confirmed with the
dose-response effect of DNMT3A, as shown in Figure
3B. In contrast, the research on epigenetic regulation
of klotho gene and some antitumor genes showed that
hypermethylation in the promoter region reduced gene
expression (Jones and Baylin, 2002; Wang et al., 2011;
Rubinek et al., 2012). The overexpression of DNMT3A
resulted in a much greater increase in reporter activity
compared with DNMT3B enzymes. In pHKP-Luc vector,
the reporter luciferase is under the control of about ~2.1
kbp upstream of human klotho gene, whereas pHKPDIILuc and pHKPDVII-Luc contain about 400 bp upstream of
the promoter region of klotho gene. The difference between
pHKPDII-Luc and pHKPDVII-Luc is the presence of a
short enhancer sequence in the former plasmid (Turan and
Ata, 2011). The results shown in Figure 3 suggested that
the DNMT3A and 3B enzymes used in this work affect a
common klotho promoter region in the reporter vector.
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Figure 5. A. Quantitation of DNMT3A transcript in stably transfected HEK-293 that knocked down with DNMT3AsiRNA. DNMT3A transcripts amplified with RT-PCR were analyzed with 7.5% native polyacrylamide gel. B. Reporter
luciferase activity in the HEK293 and stably transfected HEK293 cells after 48 h of transfection with DNMT3A-specific
siRNA.

It is suggested that DNMT enzymes downregulate
gene expression by at least two different mechanisms.
First, they change the chromatin structure by stimulating
the binding of methyl-CpG binding protein (MeCP) on
CpG sequences (Nan et al., 1996). Two types of MeCP
(MeCP1 and MECP2) proteins specifically binding to
methylated CpG sites have been characterized (Bhakat and
Mitra, 2003; Wang et al., 2003). These proteins facilitate
the binding of histone deacetylase complex and suppress
gene expression. When considered in this context, a
reporter gene located on a plasmid vector can give a
different response to DNA methylation because it is not
organized into chromatin. However, Bhakat and Mitra
(1993) reported that methylation of O6-methylguanine
DNA methyl transferase (MGMT) gene promoter located
on the plasmid decreased the reporter gene expression
at 10–12-fold, in contrast with our results (Figure 3).
Therefore, indirect mechanisms for up- or downregulation
of the promoter region carried on the plasmid by DNA
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methylation should be considered. The second mechanism
considered effective in suppressing gene expression with
DNMT enzymes facilitates binding of transcription
inhibitors or blocking of transcriptional factors that
contribute to recruitment of RNA polymerase II and
other transcriptional factors (Hiroi et al., 2013; Wang et
al., 2014). Therefore, regulation of gene expression by
DNA methylation involves quite complex mechanisms.
As a speculative approach, the upregulation of klotho gene
promoter located on plasmid vector by overexpression of
DNMT3A and DNMT3B enzymes may occur as a result of
the blockage of transcriptional inhibitors.
The effects of DNMT enzymes on human klotho
gene expression were investigated in HEK293 cells stably
transfected with reporter plasmid vectors. The results
showed that the overexpression of hDNMT3B variants
decreased more than 50% of reporter luciferase activity
in the stably transfected cells with pHKP-luc reporter
vector, while these variants showed negligible effects on
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klotho promoter activity in the other stably transfected
cells (Figure 4). No significant inhibition of reporter
luciferase activity was observed in pHKP-luc cells
expressing hDNMT3A. hDNMT3A expression in other
stably transfected cells showed a statistically important
decrease in klotho promoter activity. Different levels of a
downregulating effect of DNMT enzymes may depend
on the expression levels or different action mechanisms
of these enzymes in the cells. As an alternative, the
endogenous DNMT3A level in stably transfected cells
decreased with gene-specific siRNA transfection (Figure
5A) and the measured reporter luciferase activities. A
statistically significant increase in reporter luciferase
activity in the cells was observed (Figure 5B). These results
suggest that the expression of human klotho gene organized
as chromatin is downregulated with DNA methylation.
In conclusion, we investigated the effects of DNMT
enzymes responsible for de novo methylation in human

klotho gene expression. The results showed that DNMT
enzymes responsible for de novo methylation in human
cells upregulated the human klotho gene promoter
located on plasmid vectors when it was not organized as
a chromatin structure. In contrast, klotho gene promoter
organized as a chromatin structure was downregulated
by DNMT enzymes. These results suggest that the DNA
methylation as an epigenetic factor has great importance
for human klotho gene expression, and that chromatin
structure is necessary for DNA methylation with DNMT3A
and DNMT3B enzymes.
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